N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Intermediate High Purity

Apejuwe kukuru:

Orukọ: N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea

Synonyms: Imatinib Mesylate Intermediate

CAS: 152460-10-1

Irisi: Light Orange to Yellow Powder to Crystal

Mimọ: ≥98.0% (HPLC)

Aarin Imatinib Mesylate (CAS: 220127-57-1) ni itọju Philadelphia Chromosome-Rere Chronic Myeloid Leukemia (Ph + CML)

Inquiry: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali N- (5-Amino-2-methylphenyl)-4- (3-pyridyl) -2-pyrimidinea.
Awọn itumọ ọrọ sisọ Imatinib Mesylate Intermediate;2- (5-Amino-2-methylanilino) -4- (3-pyridyl) pyrimidine
Nọmba CAS 152460-10-1
NỌMBA CAT RF-PI230
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C16H15N5
Òṣuwọn Molikula 277.32
Ojuami Iyo 133.0-135.0 ℃
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Light Orange to Yellow Powder to Crystal
Mimọ / Analysis Ọna ≥98.0%
Pipadanu lori Gbigbe ≤0.50%
Aloku lori iginisonu ≤0.50%
Lapapọ Awọn Aimọ ≤2.0%
O pọju Nikan Aimọ ≤1.0%
Awọn Irin Eru ≤20ppm
Igbeyewo Standard Standard Enterprise
Lilo Laarin Imatinib Mesylate (CAS: 220127-57-1)

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.

Awọn anfani:

1

FAQ:

Ohun elo:

Shanghai Ruifu Kemikali Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea (CAS: 152460-10-1) pẹlu didara to gaju. .
N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidinea (CAS: 152460-10-1) jẹ agbedemeji deede ni iṣelọpọ ti Imatinib Mesylate (CAS: 220127-57-1). ) API.
Imatinib mesylate jẹ moleku kekere kan ti o dẹkun c-Abl protein-tyrosine kinase, kinase pataki pataki fun afikun ti aisan lukimia myelogenous onibaje (CML).Iṣẹlẹ iyipada laarin awọn krómósómù 9 ati 22 ṣe ipilẹṣẹ chromosome Philadelphia, eyiti o ṣe agbejade amuaradagba idapọ Bcr-Ab pẹlu iṣẹ ṣiṣe aberrant kinase ti o ṣe agbega isọdi sẹẹli ni iyara.Imatinib mesylate ṣe asopọ kinase pataki yii, o dẹkun idagba ti o ni ibatan CML.Imatinib mesylate ti ṣe afihan siwaju lati ṣe idiwọ PDGFR ati awọn kinases tyrosine ti o ni nkan ṣe pẹlu c-Kit.Awọn agbekalẹ ti o ni Imatinib mesylate ni a ti lo ninu itọju awọn oriṣiriṣi awọn aarun.
Imatinib mesylate jẹ inhibitor tyrosine kinase.Ni pato pataki fun BCR-ABL, enzymu ti o ni nkan ṣe pẹlu aisan lukimia myelogenous onibaje (CML) ati awọn iru kan ti aisan lukimia lymphoblastic nla (GBOGBO).O jẹ onidalẹkun v-Abl tyrosine kinase ti o lagbara ati yiyan (IC50 = 38 nM).Tun ṣe idiwọ PDGFR ati c-kit.Afihan yiyan fun v-Abl lori nronu kan ti miiran tyrosine ati serine/threonine amuaradagba kinases.Yiyan ṣe idiwọ idagbasoke PDGF ti o ni itara ti awọn sẹẹli PB-3 ti o yipada v-abl ati awọn sẹẹli BALB/c 3T3 ti o yipada ni vitro.Ṣe afihan awọn ipa antitumor ninu awọn eku ti o ni AMuLV tabi awọn sẹẹli BABL/c 3T3 v-sis.Ṣe idiwọ ẹda SARS-CoV ati MERS-CoV in vitro (awọn iye EC50 jẹ 9.823 ati 17.689 μM, lẹsẹsẹ).

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa